Evidence map›Paper›PMID 28958078›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2018

Stable Isotope Labeling Reveals Novel Insights Into Ubiquitin-Mediated Protein Aggregation With Age, Calorie Restriction, and Rapamycin Treatment.

Nathan B Basisty, Yuxin Liu, Jason Reynolds, Pabalu P Karunadharma, Dao-Fu Dai, Jeanne Fredrickson, Richard P Beyer, Michael J MacCoss, Peter S Rabinovitch

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Ubiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. NADCell reports · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Nathan B BasistyDepartment of Pathology, University of Washington, Seattle.
Yuxin LiuDepartment of Medicine, SUNY Upstate Medical University, Syracuse, New York.
Jason ReynoldsDepartment of Medicine, University of Washington, Seattle.
Pabalu P KarunadharmaThe Scripps Research Institute, Jupiter, Florida.
Dao-Fu DaiDepartment of Pathology, University of Washington, Seattle.
Jeanne FredricksonDepartment of Pathology, University of Washington, Seattle.
Richard P BeyerDepartment of Environmental Health, University of Washington, Seattle.
Michael J MacCossDepartment of Genome Sciences, University of Washington, Seattle.
Peter S RabinovitchDepartment of Pathology, University of Washington, Seattle.

Funding

SPECIFICITY OF OXYGEN DNA DAMAGE AND MUTAGENESISP01AG001751 · NIA · UNIVERSITY OF WASHINGTON · PI PRUSKY, GLEN THOMAS · 1985 to 2021
$29.6M
University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 1995 to 2026
$27.1M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI YATES III, JOHN R · 2012 to 2021
$20.7M
GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
Cardiomyocyte mitochondria and mtROS in cardiac aging, hypertrophy and failureR01HL101186 · NHLBI · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 2010 to 2013
$2.5M
The importance of mTOR signaling in cardiac aging and lifespan in mammalsR01AG038550 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 2010 to 2014
$1.5M
Leica SP8 WWL Confocal MicroscopeS10OD016240 · OD · UNIVERSITY OF WASHINGTON · PI CATTERALL, WILLIAM A · 2014 to 2014
$581k
NHLBI NIH HHS R01 HL101186NIA NIH HHS P01 AG001751NIA NIH HHS P30 AG013280NIA NIH HHS R01 AG038550NIA NIH HHS T32 AG000057NIGMS NIH HHS P41 GM103533NIH HHS S10 OD016240
6 · The paper itself

Abstract

Accumulation of protein aggregates with age was first described in aged human tissue over 150 years ago and has since been described in virtually every human tissue. Ubiquitin modifications are a canonical marker of insoluble protein aggregates; however, the composition of most age-related inclusions remains relatively unknown. To examine the landscape of age-related protein aggregation in vivo, we performed an antibody-based pulldown of ubiquitinated proteins coupled with metabolic labeling and mass spectrometry on young and old mice on calorie restriction (CR), rapamycin (RP)-supplemented, and control diets. We show increased abundance of many ubiquitinated proteins in old mice and greater retention of preexisting (unlabeled) ubiquitinated proteins relative to their unmodified counterparts-fitting the expected profile of age-increased accumulation of long-lived aggregating proteins. Both CR and RP profoundly affected ubiquitinome composition, half-live, and the insolubility of proteins, consistent with their ability to mobilize these age-associated accumulations. Finally, confocal microscopy confirmed the aggregation of two of the top predicted aggregating proteins, keratins 8/18 and catalase, as well as their attenuation by CR and RP. Stable-isotope labeling is a powerful tool to gain novel insights into proteostasis mechanisms, including protein aggregation, and could be used to identify novel therapeutic targets in aging and protein aggregation diseases.

Indexed as

Caloric RestrictionIsotope LabelingAgingAnimalsFemaleHalf-LifeLeucineMass SpectrometryMiceMice, Inbred C57BLMicroscopy, ConfocalProtein AggregatesProtein BiosynthesisProteomeSirolimusTOR Serine-Threonine KinasesLeucinemTOR protein, mouseProtein AggregatesProteomeSirolimusTOR Serine-Threonine KinasesUbiquitin

Identifiers

PMID28958078
PMCPMC6380815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.